HRP Anti-Lamin B1 antibody [EPR8985(B)] - Nuclear Loading Control
- BOND RX™ Validated
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(23 Publications)
Rabbit Recombinant Monoclonal Lamin B1 antibody - conjugated to HRP. Suitable for IHC-P, WB and reacts with Human, Mouse, Rat samples. Cited in 23 publications.
View Alternative Names
LMN2, LMNB, LMNB1, Lamin-B1
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - HRP Anti-Lamin B1 antibody [EPR8985(B)] - Nuclear Loading Control (AB194109)
IHC image of Lamin B1 staining in a section of formalin-fixed paraffin-embedded normal human colon tissue*, performed on a Leica BOND. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with ab194109 at 1/500 dilution, for 15 mins at room temperature. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset negative control image is taken from an identical assay without primary antibody.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre
- WB
Lab
Western blot - HRP Anti-Lamin B1 antibody [EPR8985(B)] - Nuclear Loading Control (AB194109)
ab194109 was shown to specifically react with Lamin B1 in wild-type HAP1 cells as signal was lost in LMNB1 (Lamin B1) knockout cells. Wild-type and LMNB1 (Lamin B1) knockout samples were subjected to SDS-PAGE. ab194109 and ab184095 (Mouse monoclonal [mAbcam 9484] to GAPDH - Loading Control (Alexa Fluor® 680) loading control) were incubated overnight at 4°C at 1/5000 dilution and 1/20000 dilution respectively. The loading control was imaged using the Licor Odyssey CLx prior to blots being developed with ECL technique.
All lanes:
Western blot - HRP Anti-Lamin B1 antibody [EPR8985(B)] - Nuclear Loading Control (ab194109) at 1/5000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
LMNB1 (Lamin B1) knockout HAP1 whole cell lysate at 20 µg
Predicted band size: 66 kDa
Observed band size: 70 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - HRP Anti-Lamin B1 antibody [EPR8985(B)] - Nuclear Loading Control (AB194109)
This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 3% milk before being incubated with ab194109 overnight at 4°C. Antibody binding was visualised using ECL development solution ab133406.
All lanes:
Western blot - HRP Anti-Lamin B1 antibody [EPR8985(B)] - Nuclear Loading Control (ab194109) at 1/5000 dilution
Lane 1:
Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate at 10 µg
Lane 2:
MOLT4 (Human acute lymphoblastic leukemia cell line) Whole Cell Lysate at 10 µg
Lane 3:
Y79 (Human retinoblastoma cell line) Whole Cell Lysate at 10 µg
Lane 4:
Caco 2 (Human colonic carcinoma cell line) Whole Cell Lysate at 10 µg
Predicted band size: 66 kDa
Observed band size: 70 kDa
true
Exposure time: 1min
Related conjugates and formulations (5)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Lamin B1 antibody [EPR8985(B)] - Nuclear Envelope Marker
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Lamin B1 antibody [EPR8985(B)] - Nuclear Envelope Marker
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Lamin B1 antibody [EPR8985(B)] - Nuclear Envelope Marker
-
Anti-Lamin B1 antibody [EPR8985(B)] - Nuclear Envelope Marker
-
Anti-Lamin B1 antibody [EPR8985(B)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Lamin B1 serves many important functions by providing structural integrity and regulating gene expression through chromatin organization. Part of the nuclear lamina complex Lamin B1 interacts with other lamin proteins such as Lamin A and Lamin C forming a mesh-like structure that supports the nuclear envelope. This protein also affects cellular processes such as DNA replication RNA transcription and cell division indicating its broad impact on various cellular activities.
Pathways
Lamin B1 plays an important role in gene expression regulation and cell cycle control. It interacts with pathways involved in chromatin remodeling influencing the access of transcription factors to DNA which affects gene expression profiles. Lamin B1 associates with related proteins such as Lamin A/C and other nuclear matrix proteins to maintain cellular architecture stability and normal cell function. This organization is vital to ensure the accuracy of cellular processes and prevent anomalies during cell division.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (23)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:5209 PubMed40473625
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37958946
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer research : MCR 22:181-196 PubMed37889141
2023
Applications
Unspecified application
Species
Unspecified reactive species
Signal transduction and targeted therapy 8:366 PubMed37743418
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in chemistry 10:905794 PubMed36110135
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 21:530 PubMed34641874
2021
Applications
Unspecified application
Species
Unspecified reactive species
Yonsei medical journal 62:461-469 PubMed33908218
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 21:647 PubMed33968178
2021
Applications
Unspecified application
Species
Unspecified reactive species
Drug development research 82:1044-1054 PubMed33713471
2021
Applications
Unspecified application
Species
Unspecified reactive species
PLoS genetics 17:e1009283 PubMed33539340
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com